4
Changes in Ownership
Skye Bioscience, Inc. Filed Acc 0001628280-21-018754
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
TYLE PRAVEEN · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-14 | Grant or award : show line 1 in the form Director Stock Option (Right to Buy) | +25,000 | 275,000 | D |
Loading xslF345X03/wf-form4_163182245212535.xml…